Paper Details

  1. Home
  2. Paper Details

Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline.

Author: GrungMerete, KällqvistTorsten, SakshaugSolveig, SkurtveitSvetlana, ThomasKevin V

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

An environmental risk assessment of 11 pharmaceuticals was conducted according to the European Medicines Evaluation Agency (EMEA) guidelines. The study found that ciprofloxacin, diclofenac, ethinylestradiol, sulfamethoxazole, and tetracycline had risk quotients greater than 1, suggesting potential environmental concerns.
Paper Details　
Original Abstract of the Article :
An environmental risk assessment of eleven pharmaceuticals according to the guideline recommended by the European Medicines Evaluation Agency (EMEA) was performed. Cefuroxime, ciprofloxacin, cyclophosphamide, diclofenac, ethinylestradiol, ibuprofen, metoprolol, paracetamol, sulfamethoxazole, tetracy...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.ecoenv.2007.10.015

データ提供：米国国立医学図書館（NLM）

Environmental Assessment of Norwegian Priority Pharmaceuticals: A Look at the Environmental Footprint

Pharmaceuticals, while crucial for human health, can have unintended consequences for the environment. This study aimed to assess the environmental risks of 11 priority pharmaceuticals in Norway using a guideline recommended by the European Medicines Evaluation Agency (EMEA). The study calculated predicted environmental concentrations (PECs) and compared them to predicted no effect concentrations (PNECs) to determine potential risks.

Pharmaceuticals and the Environment: A Balancing Act in the Desert of Sustainability

The study found that several pharmaceuticals, including ciprofloxacin, diclofenac, ethinylestradiol, sulfamethoxazole, and tetracycline, posed potential environmental risks based on the risk quotients calculated. This highlights the importance of considering the environmental impact of pharmaceuticals and developing strategies to minimize their release and potential harm to ecosystems. The study also underscores the need for ongoing monitoring and research to better understand the environmental fate and effects of pharmaceuticals.

Navigating Pharmaceutical Sustainability: A Desert of Innovation

This research provides valuable insights into the environmental challenges posed by pharmaceutical use. It highlights the importance of a balanced approach that prioritizes both human health and environmental sustainability. The study encourages innovation in pharmaceutical development and production to minimize environmental impacts and promote a sustainable future for both humans and the planet.

Dr.Camel's Conclusion

This research underscores the importance of considering the environmental footprint of pharmaceuticals. It highlights the need for responsible use, careful disposal, and ongoing research to minimize their potential impact on ecosystems and to ensure a sustainable future for both humans and the environment.

Date :
  1. Date Completed 2008-12-22
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

18068226

DOI: Digital Object Identifier

10.1016/j.ecoenv.2007.10.015

Related Literature

Article Analysis
・Side Effects of cefuroxime
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.